SEC 13F Intelligence

Scholtz & Company, LLC / ABT

Scholtz & Company, LLC’s Abbott Laboratories Position

Does Scholtz & Company, LLC own Abbott Laboratories (ABT)? Yes — 43.9K shares worth $5M (+2.31% of its 13F portfolio) as of Q1 2026, down from 49.2K shares the prior filed quarter.

Position Value
$5M
Q1 2026
Shares
43.9K
% of Portfolio
+2.31%
Quarters Held
30
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $5MQ4 ’18Q1 ’19: $5MQ2 ’19: $6MQ3 ’19: $6MQ4 ’19: $6MQ4 ’19Q1 ’20: $7MQ2 ’20: $8MQ3 ’20: $9MQ4 ’20: $9MQ4 ’20Q1 ’21: $10MQ2 ’21: $10MQ3 ’21: $9MQ4 ’21: $8MQ4 ’21Q1 ’22: $7MQ2 ’22: $6MQ3 ’22: $4MQ4 ’22: $4,363Q4 ’22Q1 ’23: $3,967Q2 ’23: $4,126Q3 ’23: $3,354Q4 ’23: $1,642Q4 ’23Q1 ’24: $799,257Q2 ’24: $4MQ3 ’24: $5MQ4 ’24: $5MQ4 ’24Q1 ’25: $6MQ2 ’25: $6MQ3 ’25: $6MQ4 ’25: $6MQ4 ’25Q1 ’26: $5Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202643.9K$5M+2.31%
Q4 202549.2K$6M+2.68%
Q3 202548.0K$6M+2.83%
Q2 202546.6K$6M+2.78%
Q1 202547.4K$6M+3.11%
Q4 202447.5K$5M+2.56%
Q3 202441.6K$5M+2.24%
Q2 202440.7K$4M+1.80%
Q1 20247.0K$799,257+0.35%
Q4 202314.9K$1,642+0.81%
Q3 202334.6K$3,354+2.21%
Q2 202337.8K$4,126+2.58%
Q1 202339.2K$3,967+2.83%
Q4 202239.7K$4,363+3.09%
Q3 202240.7K$4M+3.03%
Q2 202254.1K$6M+3.61%
Q1 202257.2K$7M+2.67%
Q4 202156.7K$8M+2.58%
Q3 202174.9K$9M+3.13%
Q2 202185.0K$10M+3.37%
Q1 202183.0K$10M+3.78%
Q4 202080.6K$9M+3.45%
Q3 202084.8K$9M+4.03%
Q2 202084.5K$8M+3.86%
Q1 202083.3K$7M+5.03%
Q4 201974.3K$6M+3.75%
Q3 201971.8K$6M+4.01%
Q2 201971.8K$6M+3.91%
Q1 201966.7K$5M+3.55%
Q4 201865.9K$5M+4.14%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Scholtz & Company, LLC’s full portfolio or all institutional holders of ABT.